GlaxoSmithKline PLC
1 October 2001
Directors' Interests
I give below details of changes in the directors' interests in the Ordinary
Shares and ADS Shares of GlaxoSmithKline plc.
On 30 September 2001, the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and American Depository
Shares (ADSs) in the Company under the automatic share allocation arrangements
for non-executive Directors for the period of service from 1 July to the 30
September 2001, as listed below.
Non Executive Director Ordinary Shares American Depository Shares (ADS)
Sir Richard Sykes 1,500
Sir Roger Hurn 750
Sir Peter Walters 750
Paul Allaire 125
Dr Michele Barzach 250
Sir Christopher Hogg 250
Sir Peter Job 250
John McArthur 125
Donald McHenry 125
Sir Ian Prosser 250
Dr Ronaldo Schmitz 250
Dr Lucy Shapiro 125
John Young 125
At the same time the following non-executive Directors were provisionally
allocated the following awards over Ordinary Shares and ADSs in the Company
under the share election element of the share allocation arrangements for
non-executive Directors for the period of service from 1 July to the 30
September 2001, as listed below.
Non Executive Director Ordinary Shares American Depository Shares (ADS)
Sir Roger Hurn 532.4814
Sir Peter Walters 532.4814
Sir Peter Job 599.0415
John McArthur 163.4383
Sir Ian Prosser 299.5208
Dr Ronaldo Schmitz 292.8647
John Young 399.5157
The Company and the directors were informed of these allocations on 30
September 2001.
S M Bicknell
Company Secretary
1 October 2001
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.